Photobiological activities of 1,6-dioxapyrene in pro- and eukaryotic cells.
The photobiological effect of a new pyrene derivative, 1,6-dioxapyrene (1,6-DP), was studied in Salmonella typhimurium (strain TA100) and in the diploid strain D7 of the yeast Saccharomyces cerevisiae. In Salmonella, 1,6-DP shows little mutagenicity in the dark in comparison to benzo[a]pyrene (B[a]P). This mutagenic activity decreases in the presence of liver S9 homogenates from Aroclor induced XVIInc/Z mice. However, in combination with 365 nm (UVA) radiation and in the absence of S9 mix, 1,6-DP behaves as an effective photodynamic compound inducing lethal and mutagenic effects in both organisms. In yeast, its activity, like that of B[a]P, is highly dependent on the presence of oxygen. For the same incident dose of UVA, 1,6-DP is, however, at least 6 times more effective than B[a]P in inducing cytotoxic and mutagenic effects. At equitoxic doses, 1,6-DP is as photomutagenic as B[a]P, suggesting that in both cases mutagenicity is due to similar mechanisms. Spectrophotometric measurements indicate physical interaction of 1,6-DP with DNA in the dark. Laser flash photolysis experiments show that 1,6-DP generates singlet oxygen with a quantum yield of 0.17. In vitro 1,6-DP produces oxidative damage to guanine bases specific for singlet oxygen mediated reactions. Alkaline step elution analysis of 1,6-DP plus UVA treated yeast cells indicates a decrease in average molecular weights in DNA and an induction of single strand breaks (ssb) originating from alkali labile sites. This effect is enhanced by D2O and is thus likely to be due to the production of singlet oxygen. The strand breaks appear to differ from those induced by gamma-rays because little, if any, repair of these ssb occurs during 30 min of post-treatment incubation in complete growth medium. These results suggest that the photobiological effects of 1,6-DP are due to oxidative damage in DNA mostly induced by singlet oxygen.
Averbeck
D
D
Institut Curie-Section de Biologie, CNRS URA 1292, Paris, France.
Polasa
K
K
Buisson
J P
JP
Bensasson
R
R
Rougée
M
M
Cadet
J
J
Ravanat
J L
JL
Perin
F
F
Vigny
P
P
Demerseman
P
P
D001564:Benzo(a)pyrene / Q000633:toxicity; D004249:DNA Damage; D004269:DNA, Bacterial / Q000187:drug effects / Q000378:metabolism; D004271:DNA, Fungal / Q000187:drug effects / Q000378:metabolism; D009153:Mutagens / Q000633:toxicity*; D009154:Mutation; D010084:Oxidation-Reduction; D010100:Oxygen / Q000378:metabolism; D011721:Pyrenes / Q000378:metabolism / Q000633:toxicity*; D012441:Saccharomyces cerevisiae / Q000187:drug effects / Q000235:genetics* / Q000502:physiology; D012486:Salmonella typhimurium / Q000187:drug effects / Q000235:genetics* / Q000502:physiology; D026082:Singlet Oxygen; D014466:Ultraviolet Rays
D004269:DNA, Bacterial; D004271:DNA, Fungal; D009153:Mutagens; D011721:Pyrenes; D026082:Singlet Oxygen; D001564:Benzo(a)pyrene; C081558:1,6-dioxapyrene; D010100:Oxygen